Association of IgA anti-ß2 glycoprotein i with clinical and laboratory manifestations of systemic lupus erythematosus

Journal of Rheumatology

Volumn 38, Issue 1, 2011, Pages 64-68

  Mehrani, Taraneh ^a   Petri, Michelle ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 glycoprotein I; Anti ; Antiphospholipid antibodies; Systemic lupus erythematosus

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN A ANTIBODY;

ADULT; AGED; ARTICLE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROKE; SUPERFICIAL THROMBOPHLEBITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; FEMALE; HUMANS; IMMUNOGLOBULIN A; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; YOUNG ADULT;

EID: 78650875559     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100568     Document Type: Article

References (23)

1. 2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. J Rheumatol 1998;25:675-80.
2. 2-glycoprotein I in patients with systemic lupus erythematosus. J Rheumatol 1998;25:74-8.
3. 2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus. Am J Med Sci 1999;318:55-60. (Pubitemid 30387276)
4. 2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 2006;33:1775-9.
5. 2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus. J Rheumatol 2001;28:520-4.
6. 2-glycoprotein I antibodies: importance of IgA isotype. Clin Exp Immunol 1999;117:574-9.
7. 2-glycoprotein I is the most frequent isotype. Lupus 1999;9:33-41.
8. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
10. Petri M, Rheinschmidt M, Whiting-O'Keefe Q, Hellmann D, Corash L. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and cardiolipin antibody level. Ann Intern Med 1987;106:524-31.
11. Somers E, Magder LS, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with SLE. J Rheumatol 2002;29:2531-6.
12. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550-8.
13. Bombardier C, Gladman DD, Chang CH, Urowitz MB, and the Committee on Prognosis Studies in SLE. Development of the Disease Activity Index: the SLEDAI. Arthritis Rheum 1992;35:630-40.
14. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. Systemic Lupus International Collaborative Clinics: Development of a damage index in systemic lupus erythematosus. J Rheumatol 1992;29:1820-1.
15. Bertolaccini ML, Atsumi T, Contreras AE, Khamashta MA, Hughes GRV. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. J Rheumatol 2001;28:2637-43.
16. 2-glycoprotein I antibody testing in patients with pregnancy morbidity. Ann Rheum Dis 2003;62:540-3.
17. 2-gpi antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Clin Rheumatol 2006;25:199-204.
18. Cervera R, Piette J, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002;46:1019-27. (Pubitemid 34303815)
19. Asherson RA, Cervera R. Pulmonary hypertension, antiphospholipid antibodies, and syndromes. Clin Rev Allergy Immunol 2007;32:153-8.
20. Ramos-Casals M, Nardi N, Brito-Zeron P, Aguilo S, Gil V, Delgado G, et al. Atypical autoantibodies in patients with primary Sjogren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum 2006;35:312-21.
21. Fauchais AL, Lambert M, Launay D, Michon-Pasturel U, Queyrel V, Nguyen N, et al. Antiphospholipid antibodies in primary Sjogren's syndrome: prevalence and clinical significance in a series of 74 patients. Lupus 2004:13:245-8.
22. Cervera R, Garcia-Carrasco M, Font J, Ramos M, Reverter JC, Munoz FJ, et al. Antiphospholipid antibodies in primary Sjogren's syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol 1997;15:361-5. (Pubitemid 27323996)
23. Merkel PA, Chang Y, Pierangeli SS, Convery K, Harris EN, Polisson RP. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 1996;101:576-83.